(State College, PA; September 25, 2012) – INDIGO Biosciences Inc., the premier provider of nuclear receptor products and services for the drug discovery and biosciences industries, has launched its new branding, “KNOW INDIGO,” and tagline, “The Nuclear Receptor Experts.”
“Our new logo and tagline enhances our vision and mission as we continue to grow within the industry,” said Dr. Jack Vanden Heuvel, INDIGO Biosciences chief scientific officer. “We are confident that this new look and our branding, ‘KNOW INDIGO,’ will effectively communicate our unique products and services and bring us top of mind.”
INDIGO is the only company of its kind that provides nuclear receptor screening assay products and screening services to clients within the pharmaceutical, biotechnology, food, agriculture and nutraceutical industries, as well as to government research agencies and academic researchers.
In 2005, two Pennsylvania State University professors, Dr. Vanden Heuvel and Dr. Blake Peterson, recognized a high level of demand for their collective expertise to establish the core platform technology of INDIGO.
The method, called CryoMite™, provides long-term cell cryo-preservation for shipping and storage. This allows scientists, working to develop new cures or therapies, the convenience of readily available and robust cell-based reporter assays on demand. Before CryoMite™, there wasn’t anything on the market like it.
INDIGO offers the most expansive portfolio of Nuclear Receptor tools for scientists engaged in the discovery and development of novel therapeutic agents. Researchers can choose from more than 50 human and non-human nuclear receptor assays in the company’s contract screening services portfolio. In addition, INDIGO offers custom assay development, and gene expression studies. Researchers who prefer to screen in their labs can choose from more than 25 convenient, lab-in-a-box nuclear receptor assay kits.
The new look will be on display October 14-18 in booth #311 at the International Society for the Study of Xenobiotics (ISSX) in Dallas.
About INDIGO Biosciences, Inc.
INDIGO Biosciences, Inc. offers products and services focused on nuclear receptors for the drug discovery and biosciences industries. INDIGO Biosciences provides quality screening services and active ingredient determination for clients within the pharmaceutical, biotechnology, food, agriculture and nutraceutical industries and for government research agencies and academic researchers. The company’s unique processing method to cryo-preserve nuclear receptor reporter cells, named CryoMiteTM, provides long-term cryo-preservation of cells for shipping and storage and on-demand use. For more information, visit www.INDIGOBiosciences.com.